Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 3/20 | 0.36 |
| ▸ | TSHR | P16473 | 6/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.33 |
| ▸ | TP53 | P04637 | 3/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | THRA | P10827 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6435653 | 0.95 | THRB (0.36) | THRBTSHRALDH1A1TP53HIF1A | |
| SCHEMBL29854216 | 0.93 | THRB (0.37) | THRBTSHRALDH1A1TP53HIF1A | |
| SCHEMBL29649006 | 0.84 | THRB (0.32) | THRBPTPN1 | |
| SCHEMBL10626911 | 0.80 | THRB (0.38) | THRBTSHRHPGDTHRA | |
| SCHEMBL6435118 | 0.79 | THRB (0.36) | THRBHSD17B10HPGDTHRA | |
| SCHEMBL10440134 | 0.78 | THRB (0.40) | THRBTSHRALDH1A1TP53HIF1A | |
| SCHEMBL4912293 | 0.77 | THRB (0.36) | THRBTSHRHPGDTHRA | |
| SCHEMBL6437167 | 0.77 | THRB (0.32) | THRB | |
| SCHEMBL11393741 | 0.77 | THRB (0.35) | THRBTSHR | |
| SCHEMBL30410456 | 0.74 | THRB (0.40) | THRBALDH1A1TP53CYP3A4HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1198 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250389633-A1 | SYNTHETIC HUMAN CELL MIMIC PARTICLE FOR CYTOMETRIC OR COULTER DEVICE | SLINGSHOT BIOSCIENCES, INC. (US) | 2025-12-25 | — | — | US | claimed |
| US-20250298042-A1 | ENGINEERED PARTICLES AS RED BLOOD CELL MIMICS AND COMPOSITIONS CONTAINING SAME FOR HEMATOLOGY | SLINGSHOT BIOSCIENCES, INC. (US) | 2025-09-25 | — | — | US | claimed |
| EP-4608872-A2 | SIZE-TUNABLE SYNTHETIC PARTICLES WITH TUNABLE OPTICAL PROPERTIES AND METHODS FOR USING THE SAME FOR IMMUNE CELL ACTIVATION | Slingshot Biosciences, Inc. (US) | 2025-09-03 | — | — | EP | claimed |
| US-12379387-B2 | Engineered particles as red blood cell mimics and compositions containing same for hematology | SLINGSHOT BIOSCIENCES, INC. (US) | 2025-08-05 | — | — | US | claimed |
| EP-3256850-B1 | HYDROGEL PARTICLES WITH TUNABLE OPTICAL PROPERTIES AND METHODS FOR USING THE SAME | SLINGSHOT BIOSCIENCES INC (US) | 2025-07-09 | — | — | EP | claimed |
| US-12352679-B2 | Synthetic human cell mimic particle for cytometric or coulter device | SLINGSHOT BIOSCIENCES, INC. (US) | 2025-07-08 | — | — | US | claimed |
| EP-4577823-A2 | COMPOSITIONS AND METHODS FOR SINGLE WELL MULTIPLEXED CALIBRATION AND COMPENSATION | Slingshot Biosciences, Inc. (US) | 2025-07-02 | — | — | EP | claimed |
| US-20250189428-A1 | COMPOSITIONS AND METHODS FOR SINGLE WELL MULTIPLEXED CALIBRATION AND COMPENSATION | SLINGSHOT BIOSCIENCES, INC. (US) | 2025-06-12 | — | — | US | claimed |
| US-12312595-B2 | Hydrogel particles as feeder cells and as synthetic antigen presenting cells | SLINGSHOT BIOSCIENCES, INC. (US) | 2025-05-27 | — | — | US | claimed |
| US-20250164373-A1 | SYNTHETIC HUMAN CELL MIMIC PARTICLE FOR CYTOMETRIC OR COULTER DEVICE | SLINGSHOT BIOSCIENCES, INC. (US) | 2025-05-22 | — | — | US | claimed |
| EP-0667966-A1 | POLYMERIC COMPOSITIONS AND INTRAOCULAR LENSES MADE FROM SAME | ALLERGAN, INC. (US) | 1995-08-23 | — | — | EP | claimed |
| US-5359021-A | High refractive index and foldable | ALLERGAN, INC. (US) | 1994-10-25 | — | — | US | claimed |
| US-5331073-A | Dimensional stability; high refractive index | ALLERGAN, INC. (US) | 1994-07-19 | — | — | US | claimed |
| WO-1994011764-A2 | POLYMERIC COMPOSITIONS AND INTRAOCULAR LENSES MADE FROM SAME | ALLERGAN, INC. (US) | 1994-05-26 | — | — | WO | claimed |
| US-5129031-A | Heat resistance | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-07-07 | — | — | US | claimed |
| EP-0095932-B1 | THE USE OF A PARTICULATE POLYMER AS A CARRIER FOR BIOLOGICAL SUBSTANCES AND THE LIKE AND SUCH SUBSTANCES SUPPORTED ON THE CARRIER | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1986-08-06 | — | — | EP | claimed |
| EP-0095932-A1 | The use of a particulate polymer as a carrier for biological substances and the like and such substances supported on the carrier | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1983-12-07 | — | — | EP | claimed |
| US-4415704-A | A THERMOPLASTIC RESIN WITH A HALOPHENYL ACRYLATE/BUTADIENE COPOLYMER; FIREPROOFING; CARPETS | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1983-11-15 | — | — | US | claimed |
| US-4205153-A | FLAME-RETARDANT ELASTOMERS | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1980-05-27 | — | — | US | claimed |
| US-3932321-A | HOMO- AND COPOLYMERS OF HALOPHENYL ACRYLATES | JAPAN SYNTHETIC RUBBER COMPANY LIMITED (JA) | 1976-01-13 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250389633-A1 | SYNTHETIC HUMAN CELL MIMIC PARTICLE FOR CYTOMETRIC OR COULTER DEVICE | CD4, ICOS, CD69 | THRB 502/4885TSHR 225/4885ALDH1A1 3752/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.